A Bayesian adaptive design for cancer phase I trials using a flexible range of doses
Author:
Affiliation:
1. Biostatistics and Bioinformatics Research Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA
Funder
National Cancer Institute
National Center for Research Resources
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Pharmacology,Statistics and Probability
Link
https://www.tandfonline.com/doi/pdf/10.1080/10543406.2017.1372774
Reference37 articles.
1. Systematic comparison of the statistical operating characteristics of various Phase I oncology designs
2. Cancer phase I clinical trials: efficient dose escalation with overdose control
3. Patient specific dosing in a cancer phase I clinical trial
4. Incorporating Individual and Collective Ethics into Phase I Cancer Trial Designs
5. Dose escalation with overdose control using a quasi-continuous toxicity score in cancer Phase I clinical trials
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Combination L-Glutamine with Gemcitabine and Nab-Paclitaxel in Treatment-Naïve Advanced Pancreatic Cancer: The Phase I GlutaPanc Study Protocol;Biomedicines;2023-05-08
2. Phase I trial of Bermekimab with nanoliposomal irinotecan and 5-fluorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma;Scientific Reports;2022-09-02
3. Mathematical Modelling for Optimal Vaccine Dose Finding: Maximising Efficacy and Minimising Toxicity;Vaccines;2022-05-11
4. A nonparametric Bayesian method for dose finding in drug combinations cancer trials;Statistics in Medicine;2022-01-25
5. Bayesian Adaptive Designs for Phase I Trials;Principles and Practice of Clinical Trials;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3